Phosphorylation of p53 on serine 15 by ATM or ATR is a frequent modification and initiates a cascade of posttranslational modifications. To identify possible mechanisms that modulate p53 functions in recombination surveillance, we compared the nuclear localization of p53 phosphorylated on serine 15 (p53pSer15) and the key enzymes of homologous recombination (HR) after replication fork stalling. We demonstrate an almost mutually exclusive subcompartmentalization with Rad52, while p53pSer15 was colocalizing with 40-60% of the Rad51 and Mre11 foci. Therefore, possible sites of p53pSer15-dependent regulation seem to be sites of Rad51-rather than Rad52-dependent HR processes. Remarkably, the association of p53pSer15 with repair complexes containing Rad51 or Mre11 was transient, because less than 20% of the Rad51 and Mre11 foci overlapped with p53pSer15 after 6 h. When we examined colocalization and coimmunoprecipitation of p53pSer15 and the RecQ helicase BLM with recombination surveillance and proapoptotic functions, we observed colocalization within a fraction of approximately 70% of the BLM foci and stable physical interactions until 6 h after replication arrest. Our data suggest that p53pSer15 plays a dual role in the functional interactions with early complexes of Rad51-dependent recombination and with BLM-associated surveillance and signalling complexes within distinct nuclear subcompartments.
Introduction
It has become clear that replication forks frequently break and must be repaired by recombination. In mammalian cells, the cell-cycle influences double-strand break (DSB) repair, favouring nonhomologous end joining (NHEJ) in G1/S and homologous recombination (HR) in S/G2 (Rothkamm et al., 2003) . The central step of conservative HR (gene conversion, crossover events) is the DNA strand exchange reaction catalysed by Rad51, which is facilitated by the Swi/Snf2 protein family member Rad54 and its paralog Rad54B (Krejci et al., 2003; West, 2003) . However, nonconservative exchange pathways, such as single-strand annealing (SSA), do not rely on Rad51. Rad52 facilitates SSA and, additionally, stimulates filament formation of Rad51 on ssDNA during conservative HR (West, 2003) . Rad52 forms heptameric rings on DNA ends and may compete for the DNA substrate with the NHEJ-specific Kuheterodimer, thereby channeling repair into the HR versus the NHEJ pathway. Another end binding protein complex, Rad50-hMre11-Nbs1, joins two DNA substrates via interlocking hooks at the Rad50 dimerization interface (Hopfner et al., 2002) . This feature explains its multiple functions in NHEJ, telomere maintenance, sister chromatid association, and HR.
Several tumor suppressor genes have been linked to HR through genetic disorders, which are associated with severe genetic instabilities and predispose to cancer (Thompson and Schild, 2001) . Some of the corresponding gene products are required for the relocalization of recombination factors into DNA repair foci, which is an essential process during HR (Digweed et al., 2002) . Importantly, many of these tumor suppressor proteins have been purified as part of a large protein complex known as BASC (BRCA1-associated genome surveillance complex), which may represent an assembly of DSB repair surveillance factors (Wang et al., 2000) . Thus, the central component, the breast cancer-related BRCA1, directs DSB repair from NHEJ into the nonmutagenic pathway of HR (Moynahan et al., 1999) , the Mre11 complex participates in repair and signalling (Petrini, 2000) , the mismatch repair protein MSH2 inhibits DNA exchange processes between divergent sequences (Modrich and Lahue, 1996) , the RecQ helicase BLM (Bloom's syndrome protein) was proposed to participate in replication-associated DSB repair by migrating stalled replication forks and by promoting efficient and error-free repair DNA synthesis (Karow et al., 2000; Adams et al., 2003; Pedrazzi et al., 2003) , and the phospatidyl-inositol-3 (PI-3) kinase ATM (ataxia-telangiectasia mutated) regulates many of the downstream effectors and surveillance factors of HR by posttranslational modification.
Apart from the role of p53 in checkpoint control, several studies demonstrated a direct participation in DNA repair (Albrechtsen et al., 1999; Offer et al., 1999) . In particular, a large body of evidence indicates that wild-type p53 (wtp53) regulates HR independently of transcriptional transactivation, cell-cycle control, and apoptosis induction (Dudenho¨ffer et al., 1999; Saintigny et al., 1999; Willers et al., 2000; Akyu¨z et al., 2002) . Moreover, p53 was reported to interact with Rad51, Rad54, BRCA1, BRCA2, and BLM (Albrechtsen et al., 1999; Linke et al., 2003; Sengupta et al., 2003) and to recognize pairing errors in nascent heteroduplex joints (Dudenho¨ffer et al., 1998) . Recent studies also showed that p53 counteracts hyper-recombination in response to replication fork stalling Saintigny and Lopez, 2002) .
In response to ionizing irradiation, UV, cisplatin, and hydroxyurea treatment, the tumor suppressor p53 was shown in cells to be phosphorylated on serine 15 by either one of the PI-3 kinases ATM or ATR (Appella and Anderson, 2001; Gottifredi et al., 2001) . This modification is considered to be part of the stabilization process of p53, which is required to induce G1/S cell-cycle arrest and apoptosis. However, mutation of p53 on serine 15 is not sufficient to inhibit transcriptional transactivation activities (Fuchs et al., 1995) . More recently, p53 and also the serine 15 phosphorylated form were reported to associate with recombinative repair complexes at nuclear sites likely to contain DNA replication intermediates (Zink et al., 2002; Sengupta et al., 2003) . In this work, we analysed the spatial and temporal distribution of p53pSer15 with respect to the different key HR proteins after replication inhibition, to better understand a possible role of p53pSer15 in the surveillance of recombinative repair at stalled replication forks.
Results

Comparative analysis of p53pSer15 after the arrest of replication forks
To induce DSBs by blocking DNA replication, we treated CV1 cells with the elongation inhibitor aphidicolin for 24 h (Janz and . When we analysed phosphorylation of p53 on serine 15 by immunoblotting, it was detected in aphidicolin-treated cells exclusively (Figure 1 ). The level of bulk p53 protein, as detected by the mAb DO1, rose up to twofold after drug treatment. However, no significant net increases were observed for Rad51, Mre11, Rad52, and the p53 target gene products p21 and Bax (Figure 1 ) as well as for Rad54 (not shown). When we inspected Figure 1 Effect of aphidicolin treatment on protein expression. Immunoblots showing the expression of bulk p53 protein, the p53 subpopulation phosphorylated on residue 15 (p53pSer15), the p53 target gene products p21 and Bax, and the recombination enzymes Rad51, Mre11, and Rad52. CV1 cells which had been treated with the solvent DMSO (aphidicolinÀ, lanes 1 and 3) or with aphidicolin in DMSO (aphidicolin þ , lanes 2 and 4) for 24 h were harvested immediately (releaseÀ, lanes 1-2) or 1 h after treatment (release þ , lanes 3-4). The filters were probed with anti-p53 (DO1), anti-p53pSer15 (16G8), anti-p21 (556430), anti-Bax (2D2), antiRad51 (H-92), anti-Mre11 (NB 100-142), anti-Rad52 polyclonal rabbit antiserum from animal #2495, and reprobed with anti-actin antibody to control for loading differences. The positions of M r marker bands are indicated p53pSer15 at recombinative repair complexes A Restle et al the nuclear distribution of p53pSer15 by immunofluorescence microscopy, DMSO-treated cells were devoid of any specific staining for p53pSer15 (Figure 2a ). In agreement with the expression profile, numerous foci newly appeared after aphidicolin treatment and this pattern was lacking the prominent diffuse component seen for bulk p53 (not shown).
In contrast to the expression profile, the nuclear distribution of Rad51 was affected by replication blockage. Thus, aphidicolin-treated cells were characterized by a rise in the percentage of nuclei with intense Rad51 staining (7777 versus 35714%, n ¼ 5-6). Positive nuclei displayed a striking, punctate pattern without an additional diffuse component ( Figure 2a ) and a doubling of the number of cytologically detectable foci (Figure 2b ). The appearance of Mre11 foci within the nucleus of aphidicolin-versus DMSO-treated cells was missing the diffuse component. However, Mre11 staining did not display the large dots, which were seen for Rad51 accumulations with an average diameter of 800 nm. Rather, it was predominantly concentrated within smaller, evenly distributed foci, that is, displayed the so-called localization pattern II, which is specific for the period shortly after DSB generation (Mirzoeva and Petrini, 2001 ). Rad54 was seen in focal accumulations of intermediate size (average diameter: 400 nm), again with a rise in foci numbers in the nuclei of aphidicolin-treated cells (Figure 2a and b). Signals for Rad54B remained below the detection limit and, therefore, were not further investigated (not shown).
Previous fluorescence microscopy experiments showed that fluorescently labeled Rad52 protein freely diffuses through the nucleus and rapidly and reversibly interacts with DNA repair complexes upon treatment with ionizing radiation (Thompson and Schild, 2001; West, 2003) . Here, immunofluorescence microscopy identified small Rad52 foci scattered throughout the nucleus of all cells within the population, both following culture in DMSO-and aphidicolin-containing medium. Additionally, Rad52 was found to be concentrated within large aggregates (>900 nm) within the nucleoli, particularly when S-phase cells were enriched by aphidicolin treatment (aphidicolin: 43%; DMSO: 31%; untreated: 22%). A striking, nucleolar Rad52 localization during S phase has already been noticed by Liu et al. (1999) and was interpreted by a possible role of Rad52 in rDNA recombination, which may be linked to DNA replication. Figure 2 Analysis of focal immunofluorescence signals appearing in response to aphidicolin treatment. CV1 cells were treated with either DMSO or aphidicolin, washed and incubation continued in fresh culture medium for up to 6 h before fixation. Nuclear proteins were detected with specific primary antibodies against p53pSer15 (16G8), Rad51 (H-92), Mre11 (NB 100-142), Rad54 (D-18), and Rad52 (2495), and subsequently with Cy2-conjugated anti-mouse IgG (p53pSer15) or Cy3-conjugated anti-rabbit (Rad51, Mre11, and Rad52) and anti-goat (Rad54) IgG, respectively. (a) Immunofluorescence visualization of p53pSer15, Rad51, Mre11, Rad54, and Rad52 in cells after replication arrest. Cells were collected after incubation for 1 h following DMSO or aphidicolin treatment. Note that in aphidicolin-treated cells, focal signals specific for p53pSer15 newly appeared and that Rad51 and Rad54 increasingly accumulated within discrete foci. The bar represents 20 mm. (b) Quantitation of immunofluorescence signals. Mean values and s.e.m. for the total number of distinct protein accumulations were calculated after detection of p53pSer15 (n ¼ 34-38), Rad51 (n ¼ 12-32), Mre11 (n ¼ 10-33), Rad54 (n ¼ 11-25), or Rad52 (n ¼ 11-30) after DMSO and aphidicolin treatment, and 1 or 6 h after release from aphidicolin treatment p53pSer15 at recombinative repair complexes A Restle et al
Relative distribution of p53pSer15 with focal assemblies of different HR enzymes
Given that p53pSer15 associates with sites of stalled DNA replication forks , we asked for the nuclear distribution with respect to different enzymes of the HR machinery, namely with the Mre11 complex (essential for DNA repair by HR in higher vertebrate cells), Rad51 (essential for conservative HR), Rad54 (auxiliary factor during conservative HR), or Rad52 (involved in conservative and nonconservative HR) (Thompson and Schild, 2001; Krejci et al., 2003; West, 2003) . First, we used two-colour immunofluorescence to investigate the relative distribution of p53pSer15 versus Rad51 in response to aphidicolin treatment (Figure 3) . A significant fraction of the prominent Rad51 foci colocalized with focal enrichments of p53pSer15. When we subjected the fluorescence images from 11 to 17 twocolour-stained nuclei to computer-assisted evaluation, the results revealed that 38% of the nuclear Rad51 foci colocalized with p53pSer15 foci (Figure 4b ). This overlap was similarly observed, when the cells were retransferred to aphidicolin-free medium and cultivated for 1 h before fixation. Differently, after a 6 h release period, the fraction of Rad51 foci colocalizing with p53pSer15 dropped to 13%. When we inspected the Mre11 and p53 colocalization pattern, we observed a large fraction among the Mre11 foci to colocalize with p53pSer15 ( Figure 3) . Interestingly, the colocalization between Mre11 and p53pSer15 was transient, as was similarly seen with Rad51. Thus, 56% of the Mre11 foci overlapped with focal p53pSer15 signals immediately On top, two-colour-stained images and overlays depict the relative localization pattern of p53pSer15 (green) versus Rad51 (red) in cells following aphidicolin treatment and release for 0 or 6 h. Below, p53pSer15 (green) and BLM (red) were analysed correspondingly. Note the colocalization in foci of high fluorescence intensity, in the p53pSer15-Rad51 overlays from 0 h specimens and in both p53pSer15-BLM double-stained images. Some of these foci are indicated by arrowheads. The bars denote 20 mm. (b) Doublestained images were evaluated for colocalization of discrete nuclear Rad51, Mre11, Rad54, Rad52, and BLM foci with p53pSer15 foci by counting the numbers of yellow versus red foci in the merged images. Mean values including s.e.m. for the relative fraction of colocalizing versus free foci were calculated after scoring 11-17 nuclei immunostained for Rad51, 5-21 for Mre11, 8-20 for Rad52, 24-25 for Rad54, and 22-24 for BLM for each time point. For automated colocalization analysis, yellow foci were counted as detailed in Materials and methods p53pSer15 at recombinative repair complexes A Restle et al after treatment, followed by a gradual decrease down to 18% until 6 h after release. The fraction of Rad54 foci colocalizing with p53pSer15 was relatively small, even immediately after treatment (19%). Still, a statistically significant decrease of colocalization down to 13% was monitored 1 h after release (P ¼ 0.006) and this fraction was further reduced to 7% 6 h post treatment. However, a different picture emerged, when the composite stains for Rad52 and p53 were examined. Rad52 foci were mainly observed at nuclear positions distinct from p53pSer15 ( Figure 3) and from bulk p53 (not shown), thereby emphasizing the significance of the focal Rad51 and Mre11 colocalizations. Quantitative analysis of the composite stains indicated that only a small fraction of o10% of the Rad52 foci colocalized with p53pSer15 foci (Figure 4b ).
Stable association of p53pSer15 with the surveillance factor BLM
In a previous study with human fibroblasts , p53pSer15 colocalized with the RecQ helicase BLM immediately after hydroxyurea treatment. Here, we found p53pSer15 at 72% of the BLM foci (263715 per nucleus) in response to aphidicolin treatment (Figure 4a and b) . A similar overlap was observed, when the cells were retransferred to aphidicolin-free medium and cultivated for up to 6 h before fixation (285715 BLM foci per nucleus).
To study the association kinetics for p53pSer15 and BLM biochemically, we performed co-immunoprecipitation experiments. Thus, p53pSer15 was co-precipitated together with BLM from aphidicolin-treated cells ( Figure 5 ). In agreement with the observations made by immunofluorescence analysis (Figure 4a and b) , p53pSer15 was found to remain stably associated with BLM until 6 h after treatment. Unfortunately, neither anti-Rad51 serum nor anti-p53pSer15 antibodies were suitable for co-immunoprecipitation, as was previously noticed for p53pSer15 in human cells . However, when we investigated p53pSer15 interactions with Mre11, we observed a marked drop in the amount of co-precipitated p53pSer15, although total Mre11 levels remained unchanged.
Taken together, the results demonstrate a colocalization of p53pSer15 specifically with Rad51, Mre11, Rad54, and BLM but not with Rad52 after treatment with the replication inhibitor aphidicolin. Whereas sites of colocalization between p53pSer15 and Rad51, p53pSer15 and Mre11, as well as p53pSer15 and Rad54 mostly disappeared within 6 h, p53pSer15 and BLM remained stably associated. Discussion p53pSer15 colocalizes with Rad51, Mre11, and Rad54, but not with Rad52
In this work, we have analysed the spatio-temporal association of p53pSer15 with HR proteins in CV1 cells after replication fork pausing. Aphidicolin treatment induced phosphorylation of p53 on serine 15 and the resulting p53 subpopulation was mostly detectable within discrete nuclear foci, whereas total p53 protein showed both focal and diffuse nuclear staining. When we compared the localization of p53pSer15 relative to distinct Rad51 foci after replication inhibition, we scored a mean percentage of 38% of Rad51 foci to colocalize. Interestingly, a similar mean fraction was obtained for total p53 protein and Rad51 after aphidicolin treatment (36%) and after g-irradiation of S-phase cells (32%, see Zink et al., 2002) , indicating that among the p53 protein colocalizing with Rad51, 100% was phosphorylated on serine 15. After aphidicolin treatment, p53pSer15 also colocalized with Mre11 and Rad54 foci within a fraction of 56 and 19%, respectively.
To further delineate possible functions of p53 and the phosphorylated p53pSer15 variant in different HR pathways, we analysed the localization of Rad52 relative to p53. Both nucleolar and nucleoplasmic Rad52 foci displayed a striking localization at sites predominantly distinct from p53 and p53pSer15 foci in aphidicolintreated cells, suggesting an involvement in different Figure 5 Kinetics of p53pSer15 co-immunoprecipitation with BLM and Mre11 after aphidicolin treatment. Protein interactions of p53pSer15 were studied immediately after aphidicolin treatment (0 h, lane 1) or after transfer to fresh medium and further incubation for 6 h (lane 2). BLM and Mre11 were precipitated by PGS-crosslinked anti-BLM (C-18) and anti-Mre11 (NB 100-142), respectively, and precipitates were subjected to Western analysis with antibodies directed against p53pSer15 (16G8), BLM (Ab476) and Mre11 (NB 100-142). Controls of PGS-crosslinked antibodies without extract were included (lane 3) to exclude nonspecific signals from the IgG heavy chain with a molecular mass similar to p53. Arrows indicate the migration position of the full-length proteins biological processes at these loci. These differences in the nuclear partitioning are consistent with previous observations which indicated functions of p53 in Rad51-dependent gene conversion rather than Rad52-mediated SSA (Saintigny et al., 1999; Akyu¨z et al., 2002) . However, Rad52 is also required during the presynaptic phase of gene conversion to recruit Rad51 on ssDNA covered with RPA and to promote formation of the Rad51 filament (West, 2003) . Recently, Miyazaki et al. (2004) noticed that during DSB triggered gene conversion in yeast Rad52 and Rad51 form short lived complexes, as indicated by a small fraction of around 10% colocalizing foci at 30 min. Consequently, although our data suggest that Rad52 does not represent a stable component of aphidicolin-induced structures containing Rad51 and p53pSer15, the possibility remains that the small fraction of o10% of the Rad52 foci colocalizing with p53pSer15 reflect a transient association of Rad52 with these complexes.
p53pSer15 transiently associates with Rad51, Mre11, and Rad54, but remains stably complexed with BLM after release from DNA replication arrest Remarkably, within 6 h after blocking DNA synthesis, the number of colocalizing foci between p53pSer15 and Rad51, Mre11, or Rad54 were reduced to more or less background levels, while BLM foci still coincided with p53pSer15 foci to a similar degree as found immediately after replication inhibition. Thus, despite the fact that we detected similar total numbers of p53pSer15, Rad51, Mre11, and Rad54 foci until 6 h after treatment, the association of p53pSer15 with these key HR proteins was confined to the early hours after replication inhibition. From convergent biochemical studies, p53 has been proposed to interfere with HR at an initial stage. Thus, p53 specifically interacts with junction regions within Rad51-complexed heteroduplex intermediates, blocks RuvAB-promoted branch migration, and inhibits Rad51-mediated regression of stalled replication forks (Dudenho¨ffer et al., 1998; Prabhu et al., 2002; Yoon et al., 2004) . The Mre11 complex executes the earliest steps of HR, namely recognition of the DNA lesion and possibly processing of the ends as well as tethering of the exchange substrates (Hopfner et al., 2002) . Rad51 performs initial and continued strand exchange during HR. Rad54 adds a DNA tracking function for the acceleration of homology search (Krejci et al., 2003; West, 2003) . Therefore, p53pSer15 staining at sites of Mre11 and of Rad51 repair complexes at early times after aphidicolin treatment could indicate that p53pSer15 is involved in the earliest steps of HR. Consistently, p53pSer15 localization was found to a lesser extent at sites of Rad54 that is loaded subsequently to Rad51 nucleoprotein filament formation. Thus, p53pSer15 may represent a p53 subpopulation that monitors the correct alignment of the 3 0 invading end during replication-associated HR processes (Dudenho¨ffer et al., 1998) . Alternatively, p53pSer15's function at Rad51 foci may be to inhibit Rad51-mediated migration of replication forks, thereby lowering the risk of detrimental genome rearrangements (Yoon et al., 2004) .
Our previous fluorescence microscopy and biochemical study unveiled associations of p53 with chromatin complexes containing BRCA1 and MSH2 (Zink et al., 2002) . Wang et al. (2000) provided evidence for large repair surveillance complexes in the nuclear chromatin, which contain BRCA1, MSH2, BLM, Rad50-hMre11-Nbs1, and ATM, and which facilitate the downstream phosphorylation of ATM and ATR substrates, such as p53 and Nbs1 (Foray et al., 2003) . Here, we demonstrate colocalization of Mre11 with p53pSer15 and BLM with p53pSer15, which is compatible with the idea that p53pSer15 is generated at and forms a component of these rapidly assembling surveillance complexes. We also show that p53pSer15-Mre11 complexes assemble transiently, whereas p53pSer15-BLM foci are detectable for several hours after replication fork stalling. These data suggest that p53pSer15 and BLM cooperate both at early and at later stages of repair surveillance. Since BLM directly interacts with mismatch repair components (Adams et al., 2003; Pedrazzi et al., 2003) and since hMSH2-hMSH6 complexes enhance binding of p53 to Holliday junctions (Subramanian and Griffith, 2002) , we consider the possibility that p53pSer15 and BLM are involved in the correction of errors in HR repair synthesis which takes place after the initial invasion step mediated by Rad51. Additionally, both molecules modulate the migration of stalled replication forks in vitro and possibly in vivo (Karow et al., 2000; Yoon et al., 2004) . However, from HR measurements p53 and BLM are unlikely to act on the same recombination regulatory pathway. Rather, the contribution of BLM to p53-mediated recombination regulation could be the recruitment of p53 to repair foci, which leads to a net increase in p53pSer15 (Davalos and Campisi, 2003; Sengupta et al., 2003) .
In the light of previous findings (Davalos and Campisi, 2003) , BLM and p53pSer15, within the complexes that we detect 6 h after replication fork arrest, are also conceivable to synergistically induce apoptosis as a function of the accumulated DNA damage, that is, of unrepaired or repair-resistant lesions, and of repair errors. Typically, proapoptotic signal transmission by p53 relies on transcriptional transactivation of specific target genes (Levine, 1997) . Here, p53 was phosphorylated on serine 15 and stabilized after replication inhibition, but this was not accompanied by a rise in the target gene products p21 and Bax, as was similarly observed by others (Gottifredi et al., 2001; Sengupta et al., 2003) . However, from recent findings, p53pSer15 may utilize a transcription-independent route in apoptosis induction (Mihara et al., 2003) . Therefore, we speculate that after replication fork pausing p53pSer15 plays a dual role in regulating recombination and in damage signalling within distinct nuclear subcompartments, which are characterized by the presence or absence of key HR enzymes.
Materials and methods
Antibodies
The following mouse mAbs were used for both Western and immunofluorescence analysis: DO1 directed against the N-terminal amino acids 21-25 of human p53, 16G8 recognizing p53 phosphorylated on serine 15 (Cell signalling/New England Biolabs), 556430 against p21 from Pharmingen/Becton Dickinson, and 2D2 against Bax from Biocarta. For the detection of human Rad51, we used rabbit polyclonal antibodies (H-92) raised against amino acids 1-92, for Rad54 and Rad54B polyclonal goat antibodies (D-18, K-17 from Santa Cruz). For immunoblotting, immunufluorescence and immunoprecipitation of human full-length Mre11, we applied NB 100-142 from Novus Biologicals. BLM was immunodetected in Western blots with polyclonal rabbit antibodies (Ab476) from Abcam; for immunofluorescence staining and immunoprecipitation polyclonal goat antibodies (C-18) from Santa Cruz were utilized.
For immunodetection of Rad52, polyclonal rabbit antiserum was raised against the keyhole limpet hemocyanine (KLH)-coupled synthetic peptide, covering the C-terminal amino acids 351-368 from human Rad52, followed by affinity-purification (BioGenes, Berlin, Germany). Specificity for human Rad52 from animal #2495 was ensured by Western blot analysis after the expression of the recombinant protein in Escherichia coli (Benson et al., 1998) and of fluorescently tagged Rad52 in monkey cells. The preimmune serum of animal #2495 did not produce signals in Western blots or immunostained microscopic slides.
The following affinity-purified secondary antibodies were applied: Peroxidase-conjugated anti-mouse, -rabbit and -goat IgG from Biomol, Cy2-conjugated anti-mouse IgG (p53pSer15), Cy3-conjugated anti-rabbit IgG (Rad51, Mre11, and Rad52), and Cy3-conjugated anti-goat IgG (Rad54, BLM) from Dianova.
Cell culture, treatment, immunofluorescence, and cell-cycle analysis Subconfluent cultures of early passage CV1 green monkey cells were grown in DMEM supplemented with 10% FCS. Subsequently, 10 mM aphidicolin or solvent (0.02% DMSO) was included into the medium and cultivation continued for 24 h. After treatment, the slides were either fixed immediately or transferred to fresh medium for 1 or 6 h and processed for immunofluorescent staining as described previously (Zink et al., 2002) . Images were taken with an Olympus BX51 epifluorescence microscope equipped with UPLAN FI objective lenses and a thermoelectronically cooled charge-coupled device camera (model colourview 12 from Soft Imaging System, Mu¨nster), which was controlled by an IBM compatible computer. Grayscale source images were pseudocoloured, viewed, and quantitatively evaluated by the analySIS software including the mFIP module (version Auto 3.2, Soft Imaging System). For automated image analysis, that is, for the quantification of nuclear foci, a colour intensity threshold was set so that local protein enrichments stained with high fluorescence intensity were identified. A threshold, once established, was retained for all images concerning one protein combination. For all two-colour staining combinations, we assured the absence of crossreactivities of the secondary antibodies by performing controls with only one primary antibody and both secondary antibodies. To calculate the statistical significance of differences, we used Student's unpaired t-test.
For cell-cycle analysis of propidium iodide-stained cells, we followed the protocol described in Zink et al. (2002) .
The cell cultures used in this work were free from mycoplasma contamination.
Immunoprecipitation and immunoblotting
For immunoprecipitation, cellular extracts were prepared in 50 mM HEPES (pH 7.5), 150 mM NaCl, 0.1% NP40, and protease inhibitor cocktail (Roche). Extracts containing 1 mg protein each were precleared with protein G-Sepharose (PGS from Pharmacia) for 1 h and, subsequently, incubated with PGS-coupled antibodies (10 mg) for 3 h at 41C on a rotary shaker. Precipitates were washed three times and subjected to SDS-PAGE. Antibody coupling was performed as described (Zink et al., 2002) . Immunoprecipitated proteins and total homogenates of 2 Â 10 5 CV1 cells were electrophoresed on 8-12% polyacrylamide gels and Western blotted as described previously (Dudenho¨ffer et al., 1999) .
